SEC Form 4 · accession 0001273636-18-000024
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William A. Sullivan
Officer — Chief Financial Officer
Period of report
Jul 25, 2018
Accepted (ET)
Jul 27, 2018 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.25 | Jul 25, 2018 | A | 60,000 | A | — | Jul 25, 2028 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The option becomes exercisable in equal monthly installments over four years from the date of grant.